@markmark007 The CAPTEM regimen is an oral chemotherapy combination of capecitabine and temozolomide used primarily to treat neuroendocrine tumors (NETs). It typically follows a 28-day cycle, where capecitabine is taken twice daily for a set number of days, and temozolomide is added for a subsequent set of days. (AI definition)

I'm hoping for some repeat PRRT as well. Four treatments in 2024 with Lutathera.